Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2021-09-16 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 14th September, ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of a share certificate and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification about a shareholder's lost share certificate and does not contain financial data, earnings, management discussion, or any report. It is a regulatory announcement related to shareholding documentation but not a major shareholding notification or insider dealing. Given the nature of the document as a formal regulatory communication about share certificate loss, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-09-16 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the issue of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about informing the exchanges about the issuance of duplicate share certificates, including details of old and new certificate numbers and shareholders. There is no financial data, no report attached or referenced, no management or board changes, no voting results, no earnings or financial performance data. This is a regulatory announcement related to share certificates, which does not fit into categories like Annual Report, Earnings Release, or Capital Update. It is not a report publication announcement since it does not mention any report being published or attached. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2021-09-13 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting loss of share certificates and related compliance. The document is short (1717 characters) and is an intimation or notification rather than a financial report or detailed filing. It does not contain financial data, management discussion, voting results, or any other report content. It is a regulatory compliance notification about share certificate loss, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-09-13 English
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letter dated 13th September, ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI Listing Obligations and Disclosure Requirements, which pertains to share certificate management. The content is about informing the exchange of a corporate action related to share certificates, specifically the issuance of duplicates, and includes details of the certificates issued. There is no financial data, no report or financial results, no management discussion, no voting results, no legal proceedings, no capital raising, or other report types. The document is a regulatory announcement about share certificate issuance, which fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other categories.
2021-09-13 English
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith letters dated 13th September, ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is an official notification or intimation about share certificate loss, not a financial report, earnings release, or management discussion. It does not contain financial data, management changes, voting results, or any other report type content. This type of document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2021-09-13 English
Morepen Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2021 to September 28, 2021 (both days ....
AGM Information Classification · 100% confidence The document is a Notice of the 36th Annual General Meeting (AGM) of Morepen Laboratories Limited scheduled for September 28, 2021. It includes details about the meeting date, venue (virtual), agenda items such as adoption of financial statements, appointment of directors, ratification of auditor remuneration, and approval for business transfer. It also references regulatory compliance with SEBI and Companies Act provisions. The document is a formal notice inviting shareholders to the AGM and providing information on voting and participation. It does not contain the actual financial statements or detailed reports but rather the announcement and agenda for the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2021-09-08 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.